微生物驱动的精密医学:通过药物微生物组学推动药物开发
Negar Ebadpour1, Mohammad Abavisani2, Amirhossein Sahebkar3,4,5
1Immunology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
Journal of drug targeting
|May 19, 2025
概括
药物微生物生物学探讨了肠道微生物如何影响药物代谢和疗效. 了解这些微生物组与药物相互作用可以实现个性化医疗和更安全的药物开发.
科学领域:
- 微生物学 微生物学
- 药理学 药理学是指药理学的学科.
- 遗传学 是一个遗传学.
背景情况:
- 肠道微生物群通过直接和间接的机制显著影响药物代谢和疗效.
- 微生物群落可以改变药物的生物可用性,激活前药物,调节宿主反应.
- 功能失调和微生物药物代谢可以导致治疗效果降低和药物不良反应.
研究的目的:
- 提供肠道微生物群和药物之间的复杂相互作用的全面概述.
- 阐明微生物影响药理动力学和药理动力学的直接和间接机制.
- 突出药物微生物组学在推进个性化医疗和药物开发方面的潜力.
主要方法:
- 关于药物微生物组学现有研究的文献综述.
- 对药物的直接微生物转化进行分析.
- 检查通过宿主代谢和免疫系统调节介导的间接影响.
主要成果:
- 微生物群落通过酶活性直接代谢药物.
- 间接机制涉及微生物对宿主代谢途径和免疫反应的影响.
- 例如包括前药物的微生物激活 (例如,硫素) 和免疫治疗结果的调节.
结论:
- 药物微生物组学通过利用个体微生物组资料,为个性化,精确和更安全的疗法提供了一条途径.
- 诸如益生菌,便微生物群移植和微生物群分析等创新是利用这些相互作用的关键.
- 了解微生物组与药物相互作用对于药物开发和临床实践的未来至关重要.
更多相关视频
09:52A Clinical Metaproteomics Workflow Implemented within Galaxy Bioinformatics Platform to Analyze Host-Microbiome Interactions Underlying Human Disease
Published on: January 10, 2025
458
11:22Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing
Published on: October 15, 2019
27.7K
相关概念视频
Biopharmaceutics and Pharmacokinetics: Overview
1.8K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
1.8K
Analysis of Population Pharmacokinetic Data
205
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
205
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
